Call for Abstract
13th International Conference on Vascular Dementia, will be organized around the theme “”
Vascular Dementia 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vascular Dementia 2021
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Dementia may be a term that describes a good range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. and dementia is not a selected disease.. Vascular dementia, which occurs after a stroke, is that second commonest dementia type. But there are many other conditions that can will cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, like Alzheimer's disease
- Track 1-1Primary mental health care and nursing
- Track 1-2Novel therapeutics technology
- Track 1-3Novel therapeutics strategies for Dementia
- Track 1-4Mixed dementia
- Track 1-5Frontotemporal dementia
Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease. The multi-infarct dementia (MID) and vascular intellectual impedance is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes. People with vascular dementia give dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infection. Vascular dementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.
- Track 2-1Vascular dementia prognosis
- Track 2-2Young onset dementia
- Track 2-3Multi-infarct dementia
- Track 2-4Parkinson dementia
- Track 2-5Advences in vascular dementia therapy
Caregivers of dementia patients go to understand dementia in order that they will understand what the patient is going through. They need to know about underlying diseases, and how these can affect the progress of dementia. They also need to know what kind of behavior to expect. Understanding these helps them plan for his or her caregiving and to deal with things effectively , and with less stress.
- Track 3-1Dementia nursing care plan
- Track 3-2Music therapy in dementia
- Track 3-3Physiotherapy for dementia
- Track 3-4Physiotherapy for dementia
- Track 3-5Clinical features of dementia
- Track 3-6Clinical features of dementia
- Track 3-7Clinical features of dementia
- Track 3-8Clinical features of dementia
- Track 3-9Therapeutic interventions in dementia
Two drugs, gantenerumab ,and solanezumab are currently being tested. Both are designed to help remove excess beta-amyloid in the brain. The brain changes of people with this form of Alzheimer's are very similar to the brain changes of those with the more common sporadic form of Alzheimer's disease
- Track 4-1Medication side effects
- Track 4-2Medication side effects
- Track 4-3 Excess use of alcohol
- Track 4-4Vitamin deficiencies
Neurological disorders are medically defined as disorders that affect the brain as well as the nerves found throughout the human body,and the spinal cord. Structural, biochemical or electrical abnormalities in the brain, spinal cord,or other nerves can result in a range of .symptoms.
- Track 5-1 Extracellular recording
- Track 5-2 Deep brain stimulation
- Track 5-3 Stimulus artifact
- Track 5-4 Template
- Track 5-5 Digital subtraction
A physical therapy program may include exercises to strengthen muscles, improve coordination, and regain range of motion; and constraint-induced therapy, in which an unaffected limb is immobilized, causing the person to use the affected limb to regain movement and function A brain hemorrhage is bleeding in or around the brain. It is a form of stroke.In the many Causes of brain hemorrhage include high blood pressure (hypertension), abnormally weak or dilated (aneurysm) blood vessels that leak, drug abuse, and trauma
- Track 6-1epidural hematoma.
- Track 6-2 subdural hematoma.
- Track 6-3 subarachnoid hemorrhage
A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist. Some brain tumors are noncancerous (benign), and some brain tumors are cancerous (malignant). That is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects
- Track 7-1Signs and symptoms of dementia
- Track 7-2Astrocytoma
- Track 7-3Pediatric Neuro Oncology
- Track 7-4Malignant Brain Cancers and Brain Metastasis
- Track 7-5Brain Stem Tumors
- Track 7-6Meningioma
- Track 7-7Glioblastoma
- Track 7-8Glioblastoma
- Track 7-9Spine Cancer and Spine Cancer Treatment
- Track 7-10Neurotoxicity
- Track 8-1attention deficit disorders.
- Track 8-2cognitive deficit disorders.
- Track 8-3palsies.
- Track 8-4uncontrolled anger.
- Track 8-5migraine headaches.
- Track 8-6addictions.
- Track 8-7eating disorders
- Track 8-8eating disorders
Depression and anxiety disorders are different, but people with depression often experience symptoms similar to those of an anxiety disorder, such as nervousness, irritability, and problems sleeping and concentrating. But each disorder has its own causes and its own emotional and behavioral symptoms.
- Track 9-1Generalized Anxiety Disorder
- Track 9-2Obsessive-Compulsive Disorder (OCD)
- Track 9-3Panic Disorder
Treatment of dementia begins with the treatment of the underlying disease, where possible. The underlying causes of nutritional, hormonal, tumour-caused or drug-related dementia may be reversible to some extent. For many other diseases, such as Alzheimer's disease (AD), no cure has yet been discovered. However, improvement of cognitive and behavioural symptoms can be achieved through a combination of appropriate medications and other treatments, including psychotherapy.
- Track 10-1Dementia nursing care plan
- Track 10-2Music therapy in dementia
- Track 10-3Physiotherapy for dementia
- Track 10-4linical features of dementia
- Track 10-5Therapeutic interventions in dementia
Early detection of patients at risk of developing AD is of central importance. Blood-based genetic signatures can serve as early detection and as population-based screening tools. Alzheimer’s disease (AD) is a serious degenerative brain disease and the most common cause of dementia. The current available drugs for AD provide symptomatic benefit, but there is no effective drug to cure the disease. The emergence of large-scale genomic, pharmacological data provides new opportunities for drug discovery and drug repositioning as a promising strategy in searching novel drug for AD.
Alzheimer’s disease is a progressive neurodegenerative disorder characterized by deposition of amyloid plaques composed of aggregated amyloid beta plaques, and neurofibrillary tangles composed of hyperphosphorylated tau that leads to synaptic defects resulting in neuritic dystrophy and neuronal death.
- Track 11-1Proteomics in Dementia
- Track 11-2Transcriptomics in Dementia
- Track 11-3Epigenomics of Dementia
- Track 11-4Data Mining Methods for Diagnosis of Dementia
Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.
- Track 12-1Epilepsy/Seizures
- Track 12-2Stroke
- Track 12-3Brain Injury
- Track 12-4Traumatic brain injury: TBI
- Track 12-5Parkinson’s disease (PD) and PD-related disorders
- Track 12-6Prion disease
- Track 12-7Prion disease
- Track 12-8Motor neurone diseases (MND)
- Track 12-9Huntington’s disease (HD)
- Track 12-10Spinocerebellar ataxia (SCA)
- Track 12-11Spinal muscular atrophy (SMA)
While neurologists and neurosurgeons diagnose and treat diseases of the nervous system, neurologists do not do any surgery. Neurologists focus on identifying specific diagnostic neurological conditions that can be corrected with other drugs or therapies or that require strict care
- Track 13-1Microvascular decompression
- Track 13-2 Peripheral nerve surgery
- Track 13-3Brain tumour excision
- Track 13-4 Functional neurosurgery
- Track 13-5 Pituitary surgery
- Track 13-6 Cervical spine surgery
- Track 13-7Neurochemical interaction
Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.
- Track 14-1Neuroscience and neuropharmacology
- Track 14-2Novel drug target for the treatment of dementia
- Track 14-3Novel therapeutics molecule
A psychiatric disorder is a mental illness diagnosed by a mental health professional that greatly disturbs your thinking, moods, and/or behavior and seriously increases your risk of disability, pain, death, or loss of freedom.1
In addition, your symptoms must be more severe than expected response to an upsetting event, such as normal grief after the loss of a loved one. an upsetting event, such as normal grief after the loss of a loved one
- Track 15-1Depression
- Track 15-2Personality disorders
- Track 15-3Personality disorders
Neuroimaging biomarkers use brain imaging techniques in order to image the morphology (e.g., MRI), the function (e.g. fMRI), the microenvironment (e.g., perfusion MRI), the metabolism (e.g., PET-FDG), or the molecular content (e.g., MR spectroscopy) of the brain and its lesions (Boland. 2014).
Neuroimaging biomarkers of Alzheimer's Disease include measurement of beta-amyloid deposition with amyloid PET, of brain metabolism with FDG-PET, of brain and hippocampal atrophy with MRI (Bateman et al. 2012). Read more about neuroimaging biomarkers for Alzheimer's disease.
- Track 16-1 Diagnostic biomarkers
- Track 16-2Susceptibility/risk biomarker
Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease The central nervous system (CNS) controls most functions of the body and mind. It consists of two parts: the brain and the spinal cord. The brain is the center of our thoughts, the interpreter of our external environment, and the origin of control over body movement.
- Track 17-1 autonomic nerves
- Track 17-2 motor nerves
- Track 17-3 motor nerves
- Track 17-4 sensory nerves
Clinical trials are research studies conducted with human volunteers to determine whether treatments are safe and effective. Without clinical research and the help of participants, there can be no treatments, prevention or cure for Alzheimer's disease.
- Track 18-1 Interventional trials
- Track 18-2 Interventional trials
- Track 18-3Prevention trials
- Track 18-4 Observational trials
- Track 18-5Laboratory tests
- Track 18-6 Brain scans
- Track 18-7Psychiatric evaluation
- Track 18-8 Genetic tests
To diagnose Alzheimer's dementia, your primary doctor, a doctor trained in brain conditions (neurologist) or a doctor trained to treat older adults (geriatrician) will review your medical history, medication history and your symptoms. Your doctor will also conduct several tests.
- Track 19-1 Laboratory tests
- Track 19-2 Brain scans
- Track 19-3 Psychiatric evaluation
- Track 19-4 Genetic tests
Like several other adult onset neurodegenerative diseases, Alzheimer's disease is a multifactorial illness with both genetic and non-genetic causes. Recent genetic studies have identified four genes associated with inherited risk for AD (presenilin 1, presenilin 2, amyloid precursor protein, and apolipoprotein E). These genes account for about half of the total genetic risk for Alzheimer's disease.
- Track 20-1 DNA techniques